Where is Biotein located?

Biotein is headquartered in Toronto, Canada.

How many employees does Biotein have?

As of Jul 31, 2026, the latest employee count at Biotein is 1.

Where does Biotein rank among its competitors?

Biotein ranks 910th amongst 1977 active competitors, of which 452 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Antheia, which secured $24M in Jan, 2026.

Who are the top competitors of Biotein?

Biotein's top competitors include Antheia, Transcenta and Akeso. Among them, Antheia secured the most recent funding round in January, 2026.

Biotein - 2026 Company Profile, Team & Competitors

Company Details

Biotein is developing targeted therapies for age-related diseases. They use machine learning and fluorescence microscopy that capture the biomarkers, after collecting the data of biomarkers and senescent tissue they develop the targeted therapy for the related diseases.

Website: bioteinresearch.ca
Email ID: *****@bioteinresearch.ca

Key Metrics

Founded Year

2019

Location

Toronto, Canada

Stage

Unfunded

Ranked

910^th among 1977 active competitors

Employee Count

1 as on Jul 31, 2026

Similar Companies

Antheia & 2686 more

View Biotein's full profile

Biotein has not raised any funding rounds yet.

The founders of Biotein are Laiba Khan and Nina Khera.

Here are the details of Biotein's key team members:

Laiba Khan: Co-Founder of Biotein.
Nina Khera: Co-Founder of Biotein.
Contact Info: 1 email address

View details of Biotein's Founder profiles and Board Members

Biotein's employee count trend

Biotein has 1 employees as of Jul 26. Here is Biotein's employee count trend over the years:

Uncover Biotein's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biotein include Antheia, Transcenta and Akeso. Here is the list of Top 10 competitors of Biotein, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
2nd	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Temasek & 11 others	66/100
3rd	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Orbimed, Sino Biopharmaceutical & 18 others	65/100
4th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Cormorant Asset Management, Fidelity Investments ... & 14 others	64/100
5th	Fermentalg 2005, Libourne (France), Public	Innovating with algae for sustainable solutions in nutrition and environmental impact	$30.3M	Demeter, Smalt Capital & 14 others	63/100
6th	Microban 1994, Huntersville (United States), Acquired	Antimicrobial and odor control technologies for durable product protection and freshness	$64.6M	TA Associates, UBS & 1 others	63/100
7th	Dewpoint Therapeutics 2018, Boston (United States), Series D	Developer of small molecule based therapeutics	$364M	Maverick Ventures, Polaris Partners & 16 others	62/100
8th	One Biosciences 2020, Paris (France), Series A	Developer of single-cell therapeutics solutions to treat multiple health disorders	$22.4M	BLAST Premier, Redmile Group & 6 others	62/100
9th	enGene 1999, Saint laurent (Canada), Public	Developer of oral non-viral gene therapy platform	$54M	Hercules Capital, Lumira Ventures & 15 others	61/100
10th	Avalyn Pharma 2011, Seattle (United States), Public	Developer of therapies for the treatment of Idiopathic Pulmonary Fibrosis	$389M	F-Prime Capital, Perceptive Advisors & 22 others	61/100
910th	Biotein 2019, Toronto (Canada), Unfunded	Developing bio markers based therapies for age-related diseases	-	-	29/100